Association of combination statin and antihypertensive therapy with reduced Alzheimer's disease and related dementia risk.
<h4>Background</h4>Hyperlipidemia and hypertension are modifiable risk factors for Alzheimer's disease and related dementias (ADRD). Approximately 25% of adults over age 65 use both antihypertensives (AHTs) and statins for these conditions. While a growing body of evidence found sta...
Main Authors: | Douglas Barthold, Geoffrey Joyce, Roberta Diaz Brinton, Whitney Wharton, Patrick Gavin Kehoe, Julie Zissimopoulos |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0229541 |
Similar Items
-
Sex and Race Differences in the Association Between Statin Use and the Incidence of Alzheimer Disease
by: Zissimopoulos, Julie M., et al.
Published: (2017) -
The association of multiple anti-hypertensive medication classes with Alzheimer's disease incidence across sex, race, and ethnicity.
by: Douglas Barthold, et al.
Published: (2018-01-01) -
Do Patient Concerns About Antihypertensive Use For Dementia Prevention Vary By Current Use Of Antihypertensive?
by: Lee W, et al.
Published: (2019-10-01) -
Statins reduce dementia risk by 70%
by: Lyford Joanna, et al.
Published: (2000-11-01) -
Patterns of antihypertensive and statin adherence prior to dementia: findings from the adult changes in thought study
by: Zachary A. Marcum, et al.
Published: (2019-02-01)